Putri, D.A. et al. 2025. Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-mutation Colorectal Cancer. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia). 22, 1 (Aug. 2025), 6–11. DOI:https://doi.org/10.30595/pharmacy.v22i1.24298.